Sanara MedTech (NASDAQ: SMTI) shares surged 8.48% in pre-market trading on August 13, 2025, climbing to $29.80 from the previous close of $27.47.
The uptick follows the announcement of Q2 2025 financial results, where the company reported revenues of $25.83 million, surpassing estimates of $25.15 million, and a reduced net loss of $0.23 per share, better than the anticipated $0.44 loss.
Year-over-year, revenue showed a robust increase of 28.2%, and the net loss improved from $0.41 per share.
